McKesson is laying off 1,600 employees, or 4% of its U.S. workforce, in the wake of losing some key clients, .
The nation鈥檚 largest pharmaceutical distributor, McKesson started informing staff about the cuts in the middle of this month after having done a strategic review in January, according to Bloomberg.
Of late, McKesson has been active on the acquisitions front. Early this month, the company unveiled a deal to , one of Canada鈥檚 leading drug chains, from Katz Group for $2.2 billion.
And about a week before that, McKesson announced that it was buying Vantage Oncology LLC, a provider of radiation oncology, medical oncology and integrated cancer care, and Biologics Inc., an oncology pharmacy services company, for a combined $1.2 billion.
